Published in
Springer, Drug Safety, 8(45), p. 891-908, 2022
DOI: 10.1007/s40264-022-01194-z
Links
Tools
Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database
Journal article published in 2022 by
Michele Fusaroli 
,
Valentina Isgrò,
Paola Maria Cutroneo ,
Carmen Ferrajolo ,
Valentina Cirillo,
Francesca Del Bufalo ,
Emanuel Raschi ,
Elisabetta Poluzzi ,
Gianluca Trifirò
,
Valentina Isgrò,
Paola Maria Cutroneo ,
Carmen Ferrajolo ,
Valentina Cirillo,
Francesca Del Bufalo ,
Emanuel Raschi ,
Elisabetta Poluzzi ,
Gianluca Trifirò
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 